Lymphocyte-activation gene 3 (LAG-3) and T-cell Ig and mucin domain-containing protein 3 (TIM-3) are also attractive immunosuppressive targets being actively investigated in breast cancer. This evidence concerns the gene HAVCR2 and breast cancer.